Literature DB >> 27489438

Homozygous Deletion Mutation of the FERMT1 Gene in a Chinese Patient with Kindler Syndrome.

Seung Joon Oh1, Song-Ee Kim1, Sang Eun Lee1, Soo-Chan Kim1.   

Abstract

Entities:  

Year:  2016        PMID: 27489438      PMCID: PMC4969485          DOI: 10.5021/ad.2016.28.4.503

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


× No keyword cloud information.
Dear Editor: Kindler syndrome (KS, OMIM173650) is a rare autosomal recessive genodermatosis characterized by trauma-induced skin blistering, cutaneous atrophy, progressive poikiloderma and photosensitivity1. KS is caused by mutation in the FERMT1 gene1. This gene encodes kindlin-1, which regulates not only keratinocyte adhesion through β1-class integrins but also proliferation and differentiation of cutaneous stem cells by promoting αvβ6 integrin–mediated transforming growth factor-β activation and inhibiting Wnt ligand expression2. A 12-year-old Chinese boy presented with recurrent blistering after mild trauma from the age of 1 year. There is no family history. Physical examination revealed generalized skin atrophy with some scattered resolving blisters on the extremities and poikiloderma on the face and neck (Fig. 1). He has also suffered from pruritus and photosensitivity. A skin biopsy from non-blistered area on his leg revealed hyperkeratosis and epidermal atrophy (Fig. 2A). Immunofluorescence (IF) mapping of a blister showed that keratins 5 and 14 were localized at the roof of the blister while laminin 5 and type IV collagen were localized at the base (Fig. 2B, C). Electron microscopic findings of non-blistered skin revealed widening of the lamina lucida and reduplication of the lamina densa (Fig. 2D). DNA extracted from the patient's blood was processed for direct nucleotide sequencing and we detected a homozygous dinucleotide deletion mutation at c.994_995delCA in exon 8. The mutation causes frameshift and a premature stop codon (Fig. 2E). Based on these results, we diagnosed the patient with KS.
Fig. 1

Clinical features of the patient. (A, B) Poikiloderma on the face and neck. (C) Atrophic change on the dorsal aspect of hand. (D) Skin atrophy with resolving blisters on the leg.

Fig. 2

(A) Histological examination. Hyperkeratosis and epidermal atrophy (H&E, ×400). (B, C) Immunofluorescence mapping shows separation between keratin 5 (KRT5) and type IV collagen (COL4). KRT5 is localized at the roof of the blister (B) while COL4 is localized at the base (C). (D) Electron microscopic features. Stretches of lamina lucida (asterisks) and reduplication of lamina densa (arrows) (bar=2,000 nm). (E) Genetic analysis of the FERMT1 gene shows homozygous mutation at c.994_995delCA.

KS usually manifests at birth with trauma-induced skin blistering that is more prominent on the extremities and tends to regress with age3. However, as patients age, skin atrophy localized to the dorsal aspects of the hands and feet become generalized and progressive skin poikiloderma manifests. Most patients also show photosensitivity3. Although our patient had no history of mucosal lesions, mucosal involvement is common1. Histopathology and IF mapping of a blister are not informative for diagnosis because the plane of cleavage can be variable at the level of the basement membrane zone1. Transmission electron microscopy of the non-blistered skin shows extensive reduplication of the lamina densa which is a characteristic diagnostic feature of KS4. The diagnostic golden standard is sequencing of the FERMT1 gene1. To date, more than 60 FERMT1 gene mutations and 150 KS patients have been reported and one Chinese and 4 Japanese patients have been reported in Eastern Asia5 (https://grenada.lumc.nl/LOVD2/mendelian_genes/home.php?select_db=FERMT1). Most mutations cause premature termination of translation, therefore loss of kindlin-1 function and most patients are related with consanguineous marriages3. Recently, Youssefian et al.4 first reported the c.994_995delCA mutation in a 19-year-old Iranian female patient. Interestingly, that patient had no mucosal involvement except dental plaques. This may imply an association between the mutation and mucosal-sparing features. Has et al.3 suggested genotype-phenotype correlations in KS because some patients with a missense mutation or in-frame deletion demonstrate a mild phenotype. However, only two cases including ours have been reported to date and our patient might be too young to have developed mucosal lesions. Further studies are needed to clarify this association.
  5 in total

Review 1.  Kindler syndrome: extension of FERMT1 mutational spectrum and natural history.

Authors:  Cristina Has; Daniele Castiglia; Marcela del Rio; Marta Garcia Diez; Eugenia Piccinni; Dimitra Kiritsi; Jürgen Kohlhase; Peter Itin; Ludovic Martin; Judith Fischer; Giovanna Zambruno; Leena Bruckner-Tuderman
Journal:  Hum Mutat       Date:  2011-09-20       Impact factor: 4.878

2.  The Kindler syndrome: a spectrum of FERMT1 mutations in Iranian families.

Authors:  Leila Youssefian; Hassan Vahidnezhad; Mohammadreza Barzegar; Qiaoli Li; Soheila Sotoudeh; Ameneh Yazdanfar; Amir Hooshang Ehsani; Abdol-Mohammad Kajbafzadeh; Nikoo Mozafari; Nasser Ebrahimi Daryani; Farzaneh Agha-Hosseini; Sirous Zeinali; Jouni Uitto
Journal:  J Invest Dermatol       Date:  2015-01-19       Impact factor: 8.551

3.  A case of Kindler syndrome with severe esophageal stenosis.

Authors:  Atsuko Ohashi; Yukiko Kiniwa; Ryuhei Okuyama; Tomoki Kosho; Tomoaki Suga; Cristina Has; Hitomi Kubo
Journal:  Int J Dermatol       Date:  2014-12-29       Impact factor: 2.736

Review 4.  Kindler syndrome: a focal adhesion genodermatosis.

Authors:  J E Lai-Cheong; A Tanaka; G Hawche; P Emanuel; C Maari; M Taskesen; S Akdeniz; L Liu; J A McGrath
Journal:  Br J Dermatol       Date:  2008-12-11       Impact factor: 9.302

5.  Kindlin-1 controls Wnt and TGF-β availability to regulate cutaneous stem cell proliferation.

Authors:  Emanuel Rognoni; Moritz Widmaier; Madis Jakobson; Raphael Ruppert; Siegfried Ussar; Despoina Katsougkri; Ralph T Böttcher; Joey E Lai-Cheong; Daniel B Rifkin; John A McGrath; Reinhard Fässler
Journal:  Nat Med       Date:  2014-03-30       Impact factor: 53.440

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.